Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up0.06% Nasdaq Down0.01%

More On CUR.TO

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials


DiagnoCure Inc. (CUR.TO)

-Toronto

0.27 0.00(0.00%) May 23, 2:03PM EDT

Add to Portfolio
ProfileGet Profile for:
DiagnoCure Inc.
4535 Wilfrid-Hamel Boulevard
Suite 250
Quebec, QC G1P 2J7
Canada - Map
Phone: 418-527-6100
Fax: 418-527-0240
Website: http://www.diagnocure.com

Details 
Index Membership:N/A
Sector:Healthcare
Industry:Biotechnology
Full Time Employees:13

Business Summary 

DiagnoCure, Inc., a life sciences company, engages in the development and commercialization of cancer diagnostic tests for the detection and management of cancer. The company primarily focuses on molecular diagnostic tests. It has granted a worldwide exclusive license agreement to Gen-Probe for the development and commercialization of a prostate cancer test using PCA3. The company was founded in 1994 and is headquartered in Quebec, Canada.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on DiagnoCure Inc.
Key Executives 
 PayExercised
Dr. Yves Fradet M.D., F.R.C.S., 62
Co-Founder, Chairman, Chief Exec. Officer, Pres and Chief Medical Officer		180.00K0.00
Mrs. Chantal Miklosi MBA, 42
Chief Financial Officer		225.00K0.00
Mr. Fr Boivin ,
Sr. Director of Fin. and Admin.		N/AN/A
Ms. Danielle Allard M.Sc.,
Director of Intellectual Property & Corp. Affairs and Corp. Sec.		N/AN/A
Mr. Pierre Lapalme , 72
Advisor To The Pres		N/AN/A
Amounts are as of Dec 30, 2012 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in CAD.